📰 Mobile Opera News
Page 19 - Mobile Opera News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mobile Opera. Real-time updates on events, politics, business and more.
June 2, 2022
SAN FRANCISCO — New real-world data demonstrate treatment with selexipag improved outcomes in patients with pulmonary arterial hypertension associated with connective tissue disease.At the American Thoracic Society International Conference, Sean Gaine, MD, with the National Pulmonary Hypertension Unit at Mater Misericordiae Hospital in Dublin, Ireland, and colleagues reported patient
June 2, 2022
Pediatric melatonin consumption in the United States has risen more than fivefold since 2012, with related hospitalization increasing as well, according to data published Thursday in MMWR.
June 2, 2022
The COVID-19 pandemic was a likely cause for worsened disparities in buprenorphine and naltrexone access for opioid use disorder among minority groups compared with white patients, per a study published in JAMA Network Open. “Despite some progress in [medications for opioid use disorder] use, pre-pandemic evidence suggested that it was associated with frequent exposure to high out-of-pocket
June 2, 2022
An education session at the ASCO Annual Meeting will review strategies to address bias and microaggressions in the medical workplace.
June 2, 2022
Aerobic training and daily intake of pure pomegranate juice may prevent increased liver enzymes and insulin resistance in adult men, according to findings from an Iranian study published in BMC Nutrition.“As pomegranate juice contains many polyphenolic and flavonoid compounds, it has strong antioxidant properties and prevents oxidative stress in the body,” Sasan Nemati, of the
June 1, 2022
Apellis Pharmaceuticals submitted a new drug application to the FDA for intravitreal pegcetacoplan, a targeted C3 therapy for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release.The submission is based on the results of the phase 3 DERBY and OAKS studies, as well as the phase 2 FILLY study. Pegcetacoplan demonstrated reduction in
June 1, 2022
Stem cell therapy still has many hurdles to clear before becoming a viable therapeutic option for age-related macular degeneration, but it may have the potential to transform treatment in the future.“Overall, we have a huge problem with a major unmet need,” Rajesh C. Rao, MD, Leonard G. Miller Professor of Ophthalmology and Visual Sciences and associate professor in the departments of
June 1, 2022
Elevating the rheumatology’s profile to policymakers, medical students and patients through advocacy and education is critical for the specialty’s future, according to EULAR President Annamaria Iagnocco, MD.“EULAR is 75 years old but looks much younger,” Iagnocco said in her opening remarks of the EULAR 2022 Congress. “The past is what we know and serves as a
June 1, 2022
The presence of chronic obstructive pulmonary disease is not associated with intra-hospital or 1-year outcomes for patients with mitral regurgitation undergoing transcatheter mitral valve repair, data from a single-center study show.“Due to the concomitant risk factors, a relevant percentage of patients with CVD needing cardiac surgery or intervention have chronic obstructive pulmonary
May 31, 2022
SAN DIEGO — Vedolizumab and ustekinumab associated with a lower risk for infection-related hospitalizations compared with anti-tumor necrosis factor agents in patients who initiated inflammatory bowel disease therapy at an older age. “It used to be thought that IBD becomes a milder disease with age and, therefore, there never was a tremendous investment in better understanding modern